Clinical Trial Update: Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating lenalidomide for AIDS-related Kaposi's sarcoma and recurrent Kaposi's sarcoma has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Kaposi Sarcoma
• Kaposi Sarcoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-Related Kaposi Sarcoma, Recurrent Kaposi Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-07-21